Natural History, Complications and Long-Term Prognosis of Patients with Cardiac Ascites
- 1Department of Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus Campus and the Hebrew University-Hadassah Medical School, Jerusalem 91240, Israel
Abstract
Introduction and Objectives: The natural history of patients with cardiac ascites (CA) due to congestive heart failure (CHF) remains poorly documented. This study aims were to characterize the natural history of patients with CA including its complications and long-term prognosis, in comparison to patients with ascites secondary to metabolic dysfunction-associated steatotic liver disease (MASLD). Patients and Methods: We conducted a retrospective evaluation of 98 patients presenting with ascites due to either CHF (N = 51) or MASLD (N = 47). Results: Patients with CHF exhibited a higher prevalence of cardiac-specific pathology compared to patients with MASLD. Throughout the study period, both groups presented a decline in serum and ascitic total protein and albumin levels. In patients with CHF, the decline in ascitic total protein was so substantial that levels dropped below 25 g/L in 16 patients. Furthermore, Fibrosis-4 Index (FIB-4) values increased during the study, with a more significant rise observed in the patients with MASLD. Patients with CHF had a significantly longer mean survival time compared to those with MASLD (25.0 ± 3.5 vs. 17.0 ± 2.1 months, p = 0.041). Independent predictors of shorter survival included a higher monthly frequency of paracentesis and rising FIB-4 scores during the study period. Conversely, higher admission levels of ascitic fluid albumin were associated with improved survival. Conclusions: Patients with CA demonstrate better survival outcomes than those with ascites secondary to MASLD. As cardiac disease progresses, serum and ascitic albumin and total protein levels typically decline. These findings suggest that the utility of ascitic fluid analysis in the differential diagnosis of ascites may be limited in cases of advanced CHF.
Related
- Predictive value of cardiac magnetic resonance atrial and ventricular strain for adverse prognosis in patients with myocarditis: a systematic review and meta-analysis
- History of Smoking and Prognosis of Patients With Non-small Cell Lung Cancer
- Sex-specific impact of computed tomography-defined sarcopenia on postoperative complications following elective cardiac surgery in older patients.
- Natural History and Clinical Outcomes of HBeAg-Negative Chronic Hepatitis B Patients in the “Grey Zone”: A Longitudinal Cohort Study
- Impact of perioperative physical exercise on postoperative pulmonary complications in patients undergoing cardiac surgery: a systematic review and meta-analysis
BibTeX
@article{lavi2026natural,
title = {{Natural History, Complications and Long-Term Prognosis of Patients with Cardiac Ascites}},
author = {Moran Ben Yosef Lavi and Shaul Yaari and Zvi Ackerman},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218537},
url = {https://www.mdpi.com/2077-0383/15/21/8537},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Natural History, Complications and Long-Term Prognosis of Patients with Cardiac Ascites
AU - Moran Ben Yosef Lavi
AU - Shaul Yaari
AU - Zvi Ackerman
PY - 2026
DA - 2026/11/02
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218537
UR - https://www.mdpi.com/2077-0383/15/21/8537
AB - Introduction and Objectives: The natural history of patients with cardiac ascites (CA) due to congestive heart failure (CHF) remains poorly documented. This study aims were to characterize the natural history of patients with CA including its complications and long-term prognosis, in comparison to patients with ascites secondary to metabolic dysfunction-associated steatotic liver disease (MASLD). Patients and Methods: We conducted a retrospective evaluation of 98 patients presenting with ascites due to either CHF (N = 51) or MASLD (N = 47). Results: Patients with CHF exhibited a higher prevalence of cardiac-specific pathology compared to patients with MASLD. Throughout the study period, both groups presented a decline in serum and ascitic total protein and albumin levels. In patients with CHF, the decline in ascitic total protein was so substantial that levels dropped below 25 g/L in 16 patients. Furthermore, Fibrosis-4 Index (FIB-4) values increased during the study, with a more significant rise observed in the patients with MASLD. Patients with CHF had a significantly longer mean survival time compared to those with MASLD (25.0 ± 3.5 vs. 17.0 ± 2.1 months, p = 0.041). Independent predictors of shorter survival included a higher monthly frequency of paracentesis and rising FIB-4 scores during the study period. Conversely, higher admission levels of ascitic fluid albumin were associated with improved survival. Conclusions: Patients with CA demonstrate better survival outcomes than those with ascites secondary to MASLD. As cardiac disease progresses, serum and ascitic albumin and total protein levels typically decline. These findings suggest that the utility of ascitic fluid analysis in the differential diagnosis of ascites may be limited in cases of advanced CHF.
SN - 2077-0383
ER -